News

blue star

World Sight Day 2023

Around one billion people in the world suffer due to an untreated or preventable vision loss. To focus global attention on visual impairment, blindness and significance of eye health, the World…

Read More about World Sight Day 2023

Fight for Sight and Stargardt’s Connected Joint Small Grant Award

We are pleased to be able to partner with Fight For Sight this year for the Small Grant Award Scheme. The Award is now open for applications for our Stargardt’s…

Read More about Fight for Sight and Stargardt’s Connected Joint Small Grant Award

Belite Bio Trial update

The Dragon Study Phase 3, Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Tinlarebant in the Treatment of Stargardt Disease in Adolescent Subjects. The closing date…

Read More about Belite Bio Trial update

Global survey of potential participant perspectives on ocular gene therapy

A research team from Melbourne, Australia, has developed a new questionnaire on gene therapy for inherited retinal disease, known as the Attitudes to Gene Therapy for the Eye (AGT-Eye) survey.…

Read More about Global survey of potential participant perspectives on ocular gene therapy

Retina UK Professional and Annual Conference

Retina UK are holding their Professionals and Annual Conference at the University of Westminster Marylebone Campus, London on Friday 23rd June and Saturday 24th June respectively. These events are face-to-face…

Read More about Retina UK Professional and Annual Conference

Points of Light award

We are delighted to announce that the founder of Stargardt’s Connected, Bhavna Tailor, has been awarded the Prime Minister’s Points of Light Award in recognition for setting up Stargardt’s Connected…

Read More about Points of Light award